Type
. Roles of soluble fibronectin and beta 1 integrin receptors in the binding of Mycobacterium leprae to nasal epithelial cells. Clinical immunology and immunopathology. 1993;69(3):266-71.
Type
. An immunodominant 30-kDa antigen of a candidate anti-leprosy vaccine, Mycobacterium w, shares T and B cell determinants with M. leprae and M. tuberculosis. Medical microbiology and immunology. 1993;182(5):243-53.
Type
. Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic. Journal of clinical microbiology [Internet]. 1993;31(11):2947-51. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC266167/pdf/jcm00023-0121.pdf
Type
. Fibrous histiocytoid leprosy of the cornea. Cornea. 1993;12(6):532-6.
Type
. Acetylation phenotype and genotype in aboriginal leprosy patients from the north-west region of Western Australia. Pharmacogenetics. 1993;3(5):264-9.
Type
. Bacillaemia and Mycobacterium leprae cell wall antigen in paucibacillary leprosy. Indian journal of leprosy. 1993;65(3):283-8.
Type
. Epidemiology and control of leprosy--a review of progress over the last 30 years. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993;87(5):515-7.
Type
. Immunology of leprosy. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993;87(5):508-14.
Type
. Chemotherapy of leprosy--current status and future prospects. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993;87(5):500-3.
Type
. [Research in tropical medicine and primary health care in Peru]. Salud publica de Mexico. 1993;35(5):477-86.